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Central post-stroke pain of thalamic origin is an extremely distressing and often refractory disorder. There are no
well-established predictors for pain development after thalamic stroke, and the role of different thalamic nuclei is unclear.
Here, we used structural magnetic resonance imaging to identify the thalamic nuclei, specifically implicated in the generation of
central post-stroke pain of thalamic origin. Lesions of 10 patients with central post-stroke pain of thalamic origin and 10 control
patients with thalamic strokes without pain were identified as volumes of interest on magnetic resonance imaging data.
Non-linear deformations were estimated to match each image with a high-resolution template and were applied to each
volume of interest. By using a digital atlas of the thalamus, we elucidated the involvement of different nuclei with respect
to each lesion. Patient and control volumes of interest were summed separately to identify unique areas of involvement.
Voxelwise odds ratio maps were calculated to localize the anatomical site where lesions put patients at risk of developing
central post-stroke pain of thalamic origin. In the patients with pain, mainly lateral and posterior thalamic nuclei were affected,
whereas a more anterior–medial lesion pattern was evident in the controls. The lesions of 9 of 10 pain patients overlapped at
the border of the ventral posterior nucleus and the pulvinar, coinciding with the ventrocaudalis portae nucleus. The lesions of
this area showed an odds ratio of 81 in favour of developing thalamic pain. The high odds ratio at the ventral posterior
nucleus-pulvinar border zone indicates that this area is crucial in the pathogenesis of thalamic pain and demonstrates the
feasibility of identifying patients at risk of developing central post-stroke pain of thalamic origin early after thalamic insults.
This provides a basis for pre-emptive treatment studies.
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Introduction
Central post-stroke pain of thalamic origin was first described by
Dejerine and Roussy (1906) and is characterized by neuropathic
pain emerging from thalamic lesions such as infarctions or bleeds.
A prevalence of 7% of stroke patients has been reported in iso-
lated thalamic strokes (Bogousslavsky et al., 1988; Andersen et al.,
1995), although epidemiological data are scarce. Symptoms are
typically characterized by severe, burning hemibody pain contralat-
eral to the thalamic lesion, and central post-stroke pain of thalamic
origin is considered to be one of the most distressing pain syn-
dromes (Klit et al., 2009). Pain is often accompanied by sensory
abnormalities such as negative symptoms (e.g. thermosensory def-
icits) and positive symptoms (e.g. dysaesthesias). A different pattern
of sensory signs and symptoms has been suggested previously in
central post-stroke pain of thalamic origin when compared with
central post-stroke pain of non-thalamic origin, e.g. with spinal,
brainstem or cortical lesions (Riddoch, 1938a, b; Bowsher et al.,
1998), although they can be indistinguishable in individual patients
(Riddoch, 1938b; Kalita et al., 2011). Regarding supratentorial
causes of central post-stroke pain, it has been suggested that cen-
tral post-stroke pain of operculo-insular origin is associated with
dissociated thermoalgesic sensory loss due to preserved lemniscal
function, whereas central post-stroke pain of thalamic origin is usu-
ally characterized by non-dissociated symptoms (Garcia-Larrea
et al., 2010). It has also been reported that patients with central
post-stroke pain of supratentorial origin including thalamic origin
have greater deficits in sharpness and cold sensation, whereas
patients with central post-stroke pain of infratentorial origin have
greater deficits for warmth and hot pain (Bowsher et al., 1998). For
clinicians, central post-stroke pain including central post-stroke pain
of thalamic origin is a major challenge and is often refractory to
treatment (Henry et al., 2008). In many cases, the pain develops
with a delay of weeks to months after the CNS lesion (Nasreddine
and Saver, 1997). This interval without pain after the lesioning
event theoretically opens the door for pre-emptive pharmacological
strategies. Predictors would allow the early identification of patients
at risk of developing central post-stroke pain of thalamic origin
post-infarct. Such patient classification would enable pre-emptive
treatment or at least provide criteria to group patients in drug
studies. Patient age, gender and the laterality of thalamic lesions
were all found to be inconsistent predictors in the past (Klit et al.,
2009). Studies of pre-emptive therapies have been complicated by
the need for accurate predictors and insufficient statistical power.
For example, Lampl et al. (2002) studied the effect of amitriptyline
as a preventative agent in patients suffering from a thalamic lesion
in the ventral posterior complex. However, only 7 of 39 patients
studied ever went on to develop central post-stroke pain of thal-
amic origin (Lampl et al., 2002).
The exact pathophysiological mechanisms leading to central
post-stroke pain of thalamic origin are unclear. Most concepts ex-
plaining central post-stroke pain of thalamic origin approximate the
mechanism proposed by Head and Holmes (1911) and focus on a
lesion of lateral nuclei resulting in disinhibition of medial thalamic
nuclei. It is not entirely clear which thalamic nuclei are critically
involved in the generation of central post-stroke pain of thalamic
origin. Previous studies aiming at identifying the critical lesion loca-
tion with modern brain mapping techniques included very low
numbers of patients and used manual or linear atlas-to-MRI regis-
tration techniques (Montes et al., 2005; Kim et al., 2007), which
have been shown to be inferior compared with non-linear tech-
niques (Chakravarty et al., 2009b). In addition, these previous stu-
dies did not include control subjects (Montes et al., 2005; Kim
et al., 2007).
In this study, we aimed to determine the mutual lesion site in
patients with central post-stroke pain of thalamic origin in stand-
ard stereotactic space using structural MRI data. The location of
the lesioned thalamic nuclei was determined using a high-
resolution multi-structure digital 3D atlas of subcortical anatomy
previously created from serial histological data (Chakravarty et al.,
2006). We also calculated voxelwise odds ratio maps to quantify
the risk of developing central post-stroke pain of thalamic origin
with lesions of specific areas of the thalamus.
Materials and methods
Patient recruitment
Ten consecutive patients (seven males and three females) with central
post-stroke pain of thalamic origin and 10 control patients (randomly
chosen with matching for gender and lesion side) with thalamic infarct
but without central post-stroke pain of thalamic origin were recruited
from the Department of Neurology and the affiliated Interdisciplinary
Pain Centre at the Technische Universita¨t Mu¨nchen, Germany
(Supplementary Tables 1 and 2). All patients with central post-stroke
pain of thalamic origin fulfilled the diagnostic criteria for definite
neuropathic pain (Treede et al., 2008) and more specifically definite
central post-stroke pain as recently proposed (Klit et al., 2009).
Patients and controls had no other chronic pain condition. There
was no significant age difference between the groups (Mann–
Whitney U test; P = 0.27; average age of the thalamic pain group:
65.5 years; average age of the control group: 60.6 years). As an
inclusion criterion, the control patients (without central post-stroke
pain) had to have had a follow-up of at least 2 years before study
recruitment to exclude the development of pain after a longer latent
period. The range of the post-stroke interval in the control patients
was 25–62 months. For the patients with central post-stroke pain of
thalamic origin, the post-stroke interval at the time of the study varied
between 11 months and 16 years. The study was approved by the
ethics committee of the Technische Universita¨t Mu¨nchen, and written
informed consent was obtained from the participants. The study was
conducted in accordance with the Declaration of Helsinki.
Magentic resonance imaging and data
analysis
Volumetric structural MRI data were acquired on a Siemens Symphony
1.5 T Scanner with an 8-channel head coil. High-resolution whole-brain
T1-weighted MPRAGE sequences (160 slices; slice thickness: 1 mm;
voxel size: 1  1  1 mm3; flip angle: 15; field of view:
256  256 mm; repetition time: 1520 ms; echo time: 3.93 ms; inversion
time: 800 ms) were acquired in all patients and controls to determine
the lesion site and extent. Conventional whole-brain axial T2 spin-echo
and FLAIR images additionally helped to confirm the lesion extent. The
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lesions were delineated manually as volumes of interest on the original
T1-weighted MRI of all subjects using the MRIcro software version 1.4
(http://www.sph.sc.edu/comd/rorden/mricro.html; Rorden et al.,
2007). As thalamic pain is a strictly lateralized syndrome, the volume
of interest data and MRI data of the patients with left-sided thalamic
lesions were flipped about the mid-sagittal plane, such that the affected
hemisphere was always the right hemisphere. This enabled a voxelwise
analysis of the whole patient and control group. The T1-weighted MRIs
were transformed to match a high-contrast and -resolution template in
standard stereotaxic space (Montreal Neurological Institute space). The
template used was the Colin27 MRI template derived from the
voxel-by-voxel averaging of 27 MRI volumes from the same individual
(Holmes et al., 1998). MRI data were matched to this template using
the ANIMAL algorithm (Collins et al., 1995; Collins and Evans, 1997),
which estimates a non-linear transformation by defining a set of local
translations on equally spaced nodes through the optimization of the
correlation coefficient in a local neighbourhood defined around each
node. The lesions were masked out of the non-linear registration pro-
cess. To accurately match subcortical structures, the optimized
atlas-to-patient warping method validated by Chakravarty et al.
(2008) was used. Each transformation was applied to each of the
lesion volumes of interest, so that anatomical locations could be com-
pared in the same anatomical reference space. In addition, a subcortical
atlas derived from a set of serial histological data (Chakravarty et al.,
2006) was used to verify the location of the findings. This atlas was
originally derived using manually segmented histological data where
thalamic definitions are available with respect to both the Hirai and
Jones (1989) and Schaltenbrand and Wahren (1977) definitions of
the thalamic subnuclei. In addition, these definitions were warped to
fit the Colin27 MRI template. Readers are referred to Chakravarty et al.
(2006) for the specific definitions of how thalamic subnuclei were
defined in the atlas.
Since all volumes of interest were transformed to the reference
space defined by the Colin27 magnetic resonance template, anatom-
ical localization of each lesion was determined with respect to the
different thalamic nuclei using a two-step automated approach. The
volume defined by the warped region of interest and the label defining
each thalamic subnucleus (using the Hirai and Jones (1989) nomen-
clature) was recorded. This allowed us to compare the locations and
volumes of these lesions between patient and control groups (Fig. 5;
Supplementary Tables 1 and 2). Examples of representative lesions
from a patient and a control, which were normalized to the atlas,
are available in Supplementary Fig. 1.
The transformed volumes of interest were summed to plot the
critical lesion site in thalamic pain. The same was done for the control
group separately (Fig. 1).
Figure 1 (A) Cumulative (summed) lesion map of the patients with thalamic pain (n = 10) in standard stereotaxic space (MNI space).
(B) Cumulative lesion map of the control patients (n = 10) in standard stereotaxic space (MNI space). The lesion maps are overlaid on a
high-resolution T1 MRI (Colin27 MRI template) in sagittal and coronal planes (Holmes et al., 1998). The colour bars on the right indicate
the colour coding of the lesion summation. Please note the different scaling of the images in (A) compared with (B) as indicated by each
colour bar.
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In addition, voxelwise odds ratio maps (Figs 2 and 3) were calcu-
lated for the group. If Np is the number of patients with central
post-stroke pain of thalamic origin, Nc is the number of controls, Vp
is the number of patients with a lesion at a specific voxel, and Vc is the
number of controls with a lesion at a specific voxel, then the odds ratio
at each voxel can be calculated using the following formula:
OR ¼ VP NC  VCð Þ
NP  VPð ÞVC
These maps reflect the risk of developing central post-stroke pain of
thalamic origin with a lesion at a specific voxel within the thalamus. To
prevent divisions by zero during the calculation of the voxelwise odds
ratio maps, voxels with lesions in the patient group and no lesions in
the control subjects, were set to a value of 1 in the control group. We
chose this conservative substitution to avoid overestimation of the
odds ratio values and to avoid division by zero errors.
Finally, we calculated the difference between the summed lesion
maps of the pain patients minus the controls (i.e. subtraction maps;
Fig. 4) to confirm the results of the odds ratio analysis with a more
conventional approach.
Results
Five patients with central post-stroke pain of thalamic origin had
right-sided lesions and five had left-sided lesions. The same was
true for the control patients. The pain syndrome started with the
lesioning event in three of the patients. In the seven remaining
patients, the pain developed over a period of 15 days to
36 months. Clinical characteristics and the individually lesioned
nuclei of the patients and controls are listed in Supplementary
Tables 1 and 2, respectively. The ventral posterior nucleus,
Figure 2 Results of the odds ratio analysis. (A) The crosshair indicates the location of the largest odds ratio at the border of the ventral
posterior nucleus to the pulvinar in standard stereotaxic space. Sagittal and coronal planes of a high-resolution T1 MRI image are shown
(Colin27 MRI template) (Holmes et al., 1998). (B) The location of the pertinent thalamic nuclei from the digital thalamic atlas [according to
the nomenclature of Hirai and Jones (1989)] are shown in colour and overlaid on the same MRI as in A. (C) The results of the odds ratio
analysis are overlaid on sagittal and coronal slices of the same MRI as in A. Voxels with positive odds ratio values are shown in colour. The
nuclei of the thalamus from the electronic atlas are projected onto the same images. (D) Same as C, but multiple consecutive sagittal slices
are shown to depict the full extension of positive odds ratio values. The colour bar on the right indicates the colour coding of the odds ratio
results.
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pulvinar, centre median and medial geniculate nuclei were most
commonly affected in the patients with pain. All these nuclei were
lesioned in 9 of 10 patients with central post-stroke pain of thal-
amic origin (Supplementary Table 1). The largest lesion volume
was found in the pulvinar, with a median lesion volume of
569.5 mm3 (interquartile range 519 mm3) in the 10 patients
with pain. Figure 5 shows the mean volume occupied in each
thalamic subnucleus in both patients and controls. The lesions of
the pain-free control subjects most commonly affected the ventral
posterior nucleus in 8 of 10 cases, and most of those patients had
some sort of somatosensory symptoms other than pain, as shown
in Supplementary Table 2.
The lesions of 9 of the 10 patients with central post-stroke pain
of thalamic origin overlapped at the border of the pulvinar to the
ventral posterior nucleus (Fig. 1; size of the maximal lesion overlap
3 mm3). The position of the maximal lesion overlap was verified
using the Schaltenbrand and Wahren (1977) atlas labels defined in
the digital atlas used (Chakravarty et al., 2006) and were found to
coincide with the ventrocaudalis portae nucleus.
The lesion of only one of the patients with central post-stroke
pain of thalamic origin (Patient 10) did not extend to this area of
mutual involvement. However, this patient’s lesion was just
adjacent to this area.
Figure 1 and Supplementary Tables 1 and 2 clearly indicate
that the pattern of affected nuclei differs between patients with
and without pain. The control patients tended to have more
medial lesions, the patients with central post-stroke pain of thal-
amic origin had rather lateral and posterior thalamic lesions.
Moreover, the total thalamic lesion volume of the patients with
pain was clearly larger than in the patients without pain (median
volume 953.5 mm3 versus 205.5 mm3; significantly different
between groups; Mann–Whitney U test; P50.05 two-tailed).
However, there was also one patient with a relatively small
thalamic lesion having a clear-cut thalamic pain syndrome
(Patient 4).
With the odds ratio approach, we identified voxels with an odds
ratio of up to 81 in favour of having thalamic pain (Fig. 2). These
voxels where again located at the border of the pulvinar to the
ventral posterior nucleus (x/y/z coordinates of the maximal odds
ratio values: 14/23/1 and 14/23/0). These coordinates
were also within the ventrocaudalis portae nucleus as defined by
the Schaltenbrand and Wahren (1977) atlas labels (Fig. 3). In
some patients, the lesion extended into the extrathalamic capsule.
In this territory, we found, using the odds ratio paradigm, a region
immediately adjacent to the thalamus with a maximum odds ratio
value of 5.2.
Figure 3 Odds ratio map superimposed on an atlas of the thalamus with Schaltenbrand and Wahren (1977) nomenclature. (A) The entire
atlas of the basal ganglia and thalamus as per Chakravarty et al. (2006). (B) The subnuclei of the ventrocaudalis nucleus as defined in the
atlas. (C) Odds ratio map superimposed on the ventrocaudalis subnuclei. We demonstrate that high odds ratio values are defined within
the boundaries of the ventrocaudalis portae nucleus. The colour bar indicates the colour coding of the odds ratio values.
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The subtraction analysis of the lesion overlap in the patients
with central post-stroke pain of thalamic origin minus the overlap
in the controls yielded very similar results (Fig. 4) as the odds ratio
approach within the thalamus. Here, the maximal overlap was
found at the same coordinates (x/y/z coordinates 14/23/1
and 14/23/0) as for the odds ratio analysis. None of the
control patients had lesions at the two noted coordinates. The
maximal voxel value of the subtraction analysis was 9.
Discussion
This is, to the best of our knowledge, the first study applying odds
ratio values on a voxelwise basis using structural MRI data. Odds
ratio is a typical measure used in clinical studies such as
case-control studies and its application to neuroimaging data
proved useful in this study, and the results were confirmed by
the conventional subtraction analysis. The very high spatially loca-
lized odds ratios observed suggest that stereotaxically normalized
imaging data are suitable to predict whether a patient with thal-
amic stroke will develop central post-stroke pain of thalamic origin
depending on the lesion location. The results may pave the way
for a larger multi-centre study to investigate this important clinical
question in a prospective way, applying the results of the current
study (an image file displaying the area with peak odds ratio
values as a region of interest will be available at Brain online for
download and use in future studies). If a prospective trial confirms
that it is indeed possible to identify patients with acute thalamic
Figure 4 Subtraction analysis of the summed lesions of the patients with central post-stroke pain of thalamic origin minus the summed
lesions of the control patients. (A) The crosshair indicates the stereotaxic location of the largest value found in the subtraction analysis in
standard stereotaxic space. Sagittal and coronal planes of a high-resolution T1 MRI image are shown (Colin27 MRI template) (Holmes
et al., 1998). (B) The location of the pertinent thalamic nuclei from the digital thalamic atlas [according to the nomenclature of Hirai and
Jones (1989)] are shown in colour and are overlaid on the same MRI as in A. (C) The results of the subtraction analysis are overlaid on
sagittal and coronal slices of the same MRI as in A. The nuclei of the thalamus from the electronic atlas are projected onto the same
images. (D) Same as C, but multiple consecutive sagittal slices are shown to depict the full spatial extension of the results of the subtraction
analysis. The colour bar on the right indicates the colour coding of the subtraction results.
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strokes at risk of developing central post-stroke pain of thalamic
origin, this would open the door to pre-emptive strategies for
thalamic pain. As this pain condition is often extremely refractory
to medical treatment (Henry et al., 2008), primary prevention/
pre-emptive strategies seem to be the most promising approach
to move forward in therapeutic terms, and for this purpose,
reliable measures identifying patients at risk are crucial. The next
step would then be to test the usefulness of drugs such as anti-
depressants, anticonvulsants or N-methyl-D-aspartate receptor
antagonists in patients with acute thalamic lesions at the critical
(‘eloquent’) lesion site before patients develop the clinical pain
syndrome. The feasibility of such an approach is underlined by
the fact that 7 of 10 patients with pain included in this study,
developed the pain within weeks to months after the lesioning
event, whereas only three patients suffered from pain instantan-
eously after the stroke. In most patients, hence, there is a suffi-
cient time window to initiate pre-emptive treatment.
Our results are also of interest in terms of neuroanatomy. We
applied a classical lesion mapping approach to determine the site
of mutual involvement in patients suffering from central
post-stroke pain of thalamic origin. The results indicate that the
ventral posterior nucleus/pulvinar border zone is crucial for the
development of pain. We verified the location of the maximal
odds ratio values with a Schaltenbrand and Wahren (1977)
version of the digital atlas indicating that the lesion coincides
with the ventrocaudalis portae nucleus. This finding is in line
with previous observations reporting that microstimulation of
the human ventrocaudalis portae nucleus can produce painful
sensations (Lenz et al., 1993). Indeed, stimulation of this area
was more likely to produce pain than stimulation of the core of
the nucleus ventrocaudalis, and the authors concluded that
the posterior–inferior region of the thalamus, including the
ventrocaudalis portae nucleus, ‘is functionally distinct from the
cutaneous core of ventrocaudalis. The posterior-inferior region
appears to contain neural elements involved in pathways sig-
nalling pain and temperature’ (Lenz et al., 1993). Taken to-
gether, our data supports the view that central post-stroke pain
can be produced by damage to specific neural elements within
the thalamus and that lesions of the ventrocaudalis portae nu-
cleus are key in this respect. We strongly believe and our data
with high odds ratio values suggest that the exact lesion location
rather than the lesion size matters. This view is well in line with
previous literature indicating that central post-stroke pain of
thalamic origin can follow both small and large lesions of the
thalamus and that the lesion volume does not differ between
patients with somatosensory deficits with and without central
post-stroke pain of thalamic origin (Canavero and Bonicalzi,
2007). Central post-stroke pain seems to be rare in cases with
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large thalamic lesions (Kameyama, 1976, 1977), again arguing
for the importance of location rather than size of the lesion.
It has been suggested previously that the posterior part of the
ventral medial nucleus instead of the ventral posterior or
ventrocaudalis nucleus is the key region for the development of
central post-stroke pain of thalamic origin (Craig, 2003). The
VMpo has been suggested to be the relay field of thermosensory
and nociceptive lamina I fibres projecting to the dorsal posterior
insular cortex (Craig, 2002). According to Craig (2007), the
VMpo-dorsal posterior insular pathway may inhibit a limbic net-
work consisting of the medial thalamus, anterior cingulate cortex
and peri-aqueductal grey matter. Central post-stroke pain of thal-
amic origin could then be seen as a disinhibition disorder of
thermoregulatory integration (Craig, 2007). The VMpo has been
suggested to be located adjacent to the basal part of the ventral
medial nucleus (Craig et al., 1994; Blomqvist et al., 2000), which
is at the ventral posterior/pulvinar border zone. Unfortunately,
the VMpo is not part of standard thalamic atlases, and there-
fore, we have no dedicated atlas-based data on whether the
lesion volumes affect this region. Altogether, no firm conclusions
can be drawn regarding a potential role of this nucleus from
our data.
In a previous case report on a patient with central post-stroke
pain of thalamic origin, a manual atlas co-registration was used for
MRI-based identification of lesioned nuclei. The authors reported
that the thalamic lesion did involve the anterior two-thirds of the
ventral posterior lateral nucleus and the ventral posterior medial
and inferior nuclei, whereas it did not cover the ventral medial
nucleus (the authors did not specifically report on involvement
of the ventrocaudalis portae nucleus) (Montes et al., 2005).
From visual inspection of the published MRI (Montes et al.,
2005), it seems that the lesion location of this patient overlaps
with the area where we found the highest odds ratio values,
being located at the border of the ventral posterior nucleus to
the pulvinar. A more recent case series investigating three patients
with central post-stroke pain of thalamic origin found that lesions
involved the ventrocaudalis in all three patients, while lesions
extended into the ventrocaudalis portae nucleus in two of the
cases. Lesions were reportedly not affecting the VMpo (Kim
et al., 2007). In all three patients, the lesion was located at the
border of the ventral posterior nucleus to the pulvinar, and already
small inaccuracies of the used linear registration may explain ap-
parent inconsistencies with our data.
As noted, 9 of 10 of our patients with central post-stroke pain
of thalamic origin had a lesion of the ventral posterior nucleus. It is
interesting that 8 of 10 control subjects also had lesions of the
ventral posterior nucleus without developing central post-stroke
pain of thalamic origin. This emphasizes that the specific lesion
location is the critical factor putting patients at risk of developing
central post-stroke pain of thalamic origin.
The voxels with the maximal lesion overlap in the patients with
central post-stroke pain of thalamic origin were not affected in
one of the pain patients. Interestingly, the clinical pain syndrome
of this single patient is restricted to his hand, whereas the pain
affects either the whole hemibody or a whole extremity in most of
the other pain patients that we studied. This might explain the
slight mismatch regarding the lesion location of this patient. Other
possible explanations include minimal inaccuracies of the lesion
location in standard stereotaxic space due to imperfect manual
delineation of the volumes of interest, other inaccuracies from
the non-linear transformations used to warp the MRIs to match
the Colin27 MRI template, or even other minor inaccuracies in-
herent in the atlas definitions themselves. The applied algorithm
for stereotaxic normalization, ANIMAL, has been used previously
for thalamic lesion normalization in the context of postoperative
evaluation of thalamotomy lesion location and volume in patients
suffering from movement disorders (Atkinson et al., 2002). In
addition, ANIMAL’s accuracy and ability to localize sub-nuclei
and the entirety of the thalamus have been scrutinized in recent
atlas-to-patient warping validation work (Chakravarty et al., 2008,
2009a, b). As non-linear registration approaches are currently
believed to provide the best results when warping individual
brains into standard stereotaxic space, we believe that ANIMAL
is a suitable approach for the stereotaxic normalization of individ-
ual brains with thalamic lesions. However, because of interindivi-
dual anatomical variations, even non-linear methods have
limitations, and an ideal normalization of brains from different
subjects is impossible—simply because every brain is unique.
Study limitations
We found that the total lesion volume was clearly larger in
patients with central post-stroke pain of thalamic origin compared
with the randomly chosen control subjects. This is a general
problem of lesion mapping studies in which patients with deficits
tend to have larger injuries than control patients without the
behavioural/neurological problem (Rorden and Karnath, 2004). It
must be acknowledged that this could introduce bias leading to
overestimation of the odds ratio values. Moreover, more of the
patients with central post-stroke pain of thalamic origin had
strokes extending to extra-thalamic areas including white matter
areas, although maximal odds ratio values were relatively low in
these areas. That even small thalamic strokes can involve the pos-
terior limb of the internal capsule has been reported in the past
(Kim et al., 2007; Klit et al., 2009). As a cautionary note, such
white matter lesions may interfere with thalamic nuclei, sensory
thalamo-cortical pathways (Seghier et al., 2005) and their function
and may hence confound the results of our study. Ideally, only
patients with isolated thalamic lesions would have been investi-
gated or patients and control patients with equally sized lesions
and extensions outside the thalamus. However, as patients with
thalamic pain are typically an elderly population, it did not seem
feasible to recruit a reasonable number of patients when restricting
the inclusion criteria in this sense. Taken together, future studies
are needed to confirm our findings and additional MRI measures
such as diffusion tensor imaging for white matter tracking may
then help to better understand the relation of white and grey
matter damage.
The control patients had a follow-up of at least 2 years to min-
imize the likelihood that they eventually develop pain after a longer
latent period. However, one of the patients with thalamic pain did
not develop pain until 36 months after his stroke, and in one study,
a patient developing thalamic pain 9 years after the initial lesion has
been reported (Bogousslavsky et al., 1988). For practical reasons,
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our inclusion criterion for the control patients was a pain-free
interval after the thalamic stroke of at least 2 years. This seemed
sensible to us because it is rare that patients develop thalamic pain
more than 24 months after the stroke. Nevertheless, we cannot
entirely rule out that an individual control patient may still develop
central post-stroke pain of thalamic origin.
In this study, we did not investigate the patients with quantita-
tive sensory testing, which is a systematic and detailed approach to
determine the somatosensory phenotype of patients by studying
sensory thresholds (Yarnitsky, 1997; Rolke et al., 2006). The lack of
data obtained with quantitative sensory testing in our study is a
clear limitation of the present study as we are unable to correlate
the MRI findings with somatosensory deficits. Quantitative sensory
testing also holds some promise for the early identification of pa-
tients at risk of developing central post-stroke pain of thalamic
origin after thalamic lesions as it has been recently shown that
patients with early evoked dysaesthesia or pain after stroke are
at an increased risk of developing central post-stroke pain com-
pared with patients without early hypersensitivity (Klit et al.,
2011). Hence, future studies may use our MRI-driven approach
and quantitative sensory testing measures to identify patients at
risk comparing the sensitivity and specificity of the different
approaches as well as the performance of the combined approach.
In conclusion, we present data evidencing that lesions of the
ventral posterior nucleus/pulvinar border zone coinciding with the
ventrocaudalis portae nucleus are key for the development of cen-
tral post-stroke pain of thalamic origin. A prospective study eval-
uating the usefulness of this neuroimaging marker in detecting
patients at risk of developing central post-stroke pain of thalamic
origin is now warranted.
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